The government has capped prices of orthopedic knee implants at a significantly lower rate than current market rates.
In an interview to CNBC-TV18, Suneeta Reddy, Joint MD of Apollo Hospitals Enterprises spoke about the latest happenings in her company and sector.
Capping the prices of orthopedic knee implants at lower rate is feasible, she said.
Whatever is happening with the stent or the knee is not going to impact the profitability of the entire hospital significantly, she added.
Knee implants formed only 10 percent of our total revenues and volumes have started to pick up and we have moved on from just knee implants to higher clinical excellence, upped the value chain by doing something called Regrow and 3D knee, said Reddy.
We are moving up the value chain away from the implant story, she further mentioned.
For full interview, watch accompanying video...
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
